Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-15 Purchase |
2023-11-17 4:01 pm |
Gossamer Bio Inc. | GOSS | Milligan Sandra Director |
32,000 | $0.7879 | $25,213 | 32,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-31 Exercise(A) |
2025-01-29 5:20 pm |
N/A N/A |
Aspira Women's Health Inc. | AWH | Milligan Sandra Interim CEO |
20,000 | $0 | 13,644 (Direct) |
View |
| 2025-01-08 Tax Withholding(A) |
2025-01-29 5:20 pm |
N/A N/A |
Aspira Women's Health Inc. | AWH | Milligan Sandra Interim CEO |
6,356 | $0.7 | 13,644 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-08 6:35 pm |
N/A N/A |
Aspira Women's Health Inc. | AWH | Milligan Sandra Interim CEO & President |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-11-12 Option Award |
2024-11-13 8:54 pm |
2024-11-12 2034-11-12 |
Aspira Women's Health Inc. | AWH | Milligan Sandra President |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-10-28 Option Award |
2024-10-28 6:54 pm |
N/A N/A |
Aspira Women's Health Inc. | AWH | Milligan Sandra President |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-06 9:58 pm |
N/A 2034-06-05 |
Gossamer Bio Inc. | GOSS | Milligan Sandra Director |
115,000 | $0 | 115,000 (Direct) |
View |
| 2024-05-14 Option Award |
2024-05-16 4:10 pm |
N/A 2034-05-14 |
Spyre Therapeutics Inc. | SYRE | Milligan Sandra Director |
21,980 | $0 | 21,980 (Direct) |
View |
| 2024-05-03 Option Award |
2024-05-06 6:49 pm |
N/A 2034-05-03 |
Aspira Women's Health Inc. | AWH | Milligan Sandra President |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 4:14 pm |
N/A 2033-06-07 |
Gossamer Bio Inc. | GOSS | Milligan Sandra Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-05-04 Tax Withholding |
2023-05-08 6:43 pm |
N/A N/A |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
2,168 | $24.24 | 33,583 (Direct) |
View |
| 2023-05-04 Exercise |
2023-05-08 6:43 pm |
2023-05-04 2024-05-04 |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
4,984 | $0 | 33,583 (Direct) |
View |
| 2023-05-01 Tax Withholding |
2023-05-03 7:06 pm |
N/A N/A |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
826 | $24.63 | 25,783 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 7:06 pm |
2023-05-01 2023-05-01 |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
1,899 | $0 | 25,783 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 8:18 pm |
N/A N/A |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
5,964 | $0 | 170,829 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-04 8:18 pm |
2024-03-31 2026-03-31 |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
134,191 | $0 | 170,829 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 8:18 pm |
N/A N/A |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
2,115 | $23.09 | 170,829 (Direct) |
View |
| 2023-02-28 Tax Withholding |
2023-03-02 5:29 pm |
N/A N/A |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
2,346 | $25.09 | 20,861 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 5:29 pm |
2022-12-31 2022-12-31 |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
7,976 | $0 | 20,861 (Direct) |
View |
| 2022-06-09 Option Award |
2022-07-15 5:03 pm |
N/A 2032-06-08 |
Gossamer Bio Inc. | GOSS | Milligan Sandra Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-05-04 Tax Withholding |
2022-05-05 8:47 pm |
N/A N/A |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
1,806 | $32.44 | 22,057 (Direct) |
View |
| 2022-05-03 Exercise |
2022-05-05 8:47 pm |
2022-05-03 2022-05-03 |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
6,826 | $0 | 22,057 (Direct) |
View |
| 2022-05-03 Tax Withholding |
2022-05-05 8:47 pm |
N/A N/A |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
525 | $32.08 | 22,057 (Direct) |
View |
| 2022-05-01 Exercise |
2022-05-03 7:40 pm |
2022-05-01 2023-05-01 |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
1,896 | $0 | 12,632 (Direct) |
View |
| 2022-05-01 Tax Withholding |
2022-05-03 7:40 pm |
N/A N/A |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
540 | $32.33 | 12,632 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 6:06 pm |
2023-03-31 2025-03-31 |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
73,006 | $0 | 73,006 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 6:46 pm |
2021-12-31 2021-12-31 |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
10,171 | $0 | 9,380 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-03-02 6:46 pm |
N/A N/A |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
2,941 | $37.57 | 9,380 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-19 5:14 pm |
2022-08-17 2031-08-16 |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
22,321 | $0 | 22,321 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:26 pm |
N/A 2031-06-09 |
Gossamer Bio Inc. | GOSS | Milligan Sandra Director |
47,000 | $0 | 47,000 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-04 9:27 pm |
2022-05-03 2022-05-03 |
Organon & Co. | OGN | Milligan Sandra Head of Research & Development |
426,542 | $0 | 428,692 (Direct) |
View |